Feature Channels: Blood

• share
• favorite_border

Don't miss these articles in our Staff Picks channel

• share
• favorite_border

The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released a new guideline for the management of Kawasaki disease that addresses diagnostic issues relating to the disease, the treatment of high-risk patients, & the management of convalescent patients.

• share
• favorite_border

Black and Hispanic people with acute myeloid leukemia in greater Chicago were more likely to die from the disease than their non-Hispanic white counterparts, with a 59% and 25% greater risk, respectively, according to a new study led by University of Illinois Chicago researchers.  

• share
• favorite_border

The Vasculitis Foundation (VF) is pleased to announce an exciting new initiative: Vasculitis-Building Outcomes, Leading Discoveries (V-BOLD), which combines three of the VF’s most critical programs: Fellowships, Vasculitis Centers, and Research.

• share
• favorite_border

An international team of scientists has found new biomarkers that can be used for diagnostic purposes and potentially as predictive tools of the risks associated with deep space flight.

• share
• favorite_border

• share
• favorite_border

Chicago residents and visitors now have access to lifesaving STOP THE BLEED® kits as the city expands its Safe Chicago initiative.

• share
• favorite_border

Dr. Masi Shah of Rutgers Cancer Institute in partnership with RWJBarnabas Heath shares about Multiple Myeloma, a life changing disease with treatments to help control the disease.

• share
• favorite_border

Announcement of contents of the March 2022 issue of Neurosurgical Focus: Video

• share
• favorite_border

Johns Hopkins Medicine researchers have developed and tested a new imaging approach they say will accelerate imaging-based research in the lab by allowing investigators to capture images of blood vessels at different spatial scales.

• share
• favorite_border

• share
• favorite_border

Despite the lifesaving success of the COVID-19 vaccines, very rare side effects have emerged. Vaccines engineered from the otherwise-mild adenovirus, for example, have been linked to blood clots. Scientists from Arizona State University, the Mayo Clinic, AstraZeneca and elsewhere have performed simulations on PSC’s Bridges-2 system that suggest simple electrical charge may make a protein involved in blood clot formation stick to particles of the AstraZeneca vaccine. The discovery will be the foundation of an effort to explain how the side effect happens and how the vaccine can be re-engineered to prevent it.

• share
• favorite_border

A collaborative effort between The Valley Heart and Vascular Institute’s cardiology and structural heart teams, at The Valley Hospital, in Ridgewood, NJ, uncovers an underlying condition and mitigates James Freehill's symptoms.

• share
• favorite_border

A blood test developed at Washington University School of Medicine in St. Louis has proven highly accurate in detecting early signs of Alzheimer’s disease in a study involving nearly 500 patients from across three continents, providing further evidence that the test should be considered for routine screening and diagnosis. The study is available in the journal Neurology.

• share
• favorite_border

Over 90 percent of patients with transfusion-dependent thalassemia, an inherited blood disorder, no longer needed monthly blood transfusions years after receiving gene therapy, according to an international Phase 3 clinical trial that for the first time included children younger than 12 years of age. Twenty-two patients were evaluated (ranging in age 4-34 years), including pediatric patients enrolled at Ann & Robert H. Lurie Children’s Hospital of Chicago.

• share
• favorite_border

The Latest Research News in Cardiovascular Health

• share
• favorite_border

Sickle cell anemia is an inherited blood disorder where red blood cells become sickle/crescent shaped. It causes frequent infections, swelling in the hands and legs, pain, severe tiredness and delayed growth or puberty.

• share
• favorite_border

Texas Tech University Health Sciences Center El Paso has received more than a quarter-million dollars to study the proteins that contribute to disease progression and drug resistance in acute myeloid leukemia.

• share
• favorite_border

Scientists have discovered that “rogue” antibodies found circulating in the blood of COVID-19 patients have the potential to cause endothelial cells to lose their resistance to clotting. These antiphospholipid autoantibodies can trigger blood clots in the arteries and veins of patients with autoimmune disorders, including lupus and antiphospholipid syndrome. The findings provide an even stronger connection between autoantibody formation and clotting in COVID-19.